Bill Title: To amend the Federal Food, Drug, and Cosmetic Act to authorize the use of investigational individualized medical treatments by patients diagnosed with a life-threatening disease or condition or severely debilitating illness, and for other purposes.

Sponsorship: Partisan Bill (Republican 2)

Status: (Introduced) 2026-06-08 - Referred to the House Committee on Energy and Commerce. [HB9190 Detail]

Text: Not Available

---

PolitiCorps Conversations

Start PolitiCorps Debate

Title	PolitiCorps	Access	Comments	Views	Last Post
There are no visible public or private PolitiCorps discussions concerning the 2025 US Congress HB9190 at this time.